Ironwood Pharmaceuticals annual return on equity
2011
2012
2015
2016
2017
2021
2022
2023
Ironwood Pharmaceuticals Return on Equity (ROE) Growth & History (IRWD)
Ironwood Pharmaceuticals's return on equity was −654.88% for fiscal 2023.
View full Ironwood Pharmaceuticals company overviewIronwood Pharmaceuticals annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −654.88% | −682.71 pp |
| 2022 | 2022-12-31 | 27.83% | −130.26 pp |
| 2021 | 2021-12-31 | 158.09% | — |
| 2017 | 2017-12-31 | −305.46% | −204.49 pp |
| 2016 | 2016-12-31 | −100.97% | +54.37 pp |
| 2015 | 2015-12-31 | −155.35% | — |
| 2012 | 2012-12-31 | −57.20% | −9.06 pp |
| 2011 | 2011-12-31 | −48.14% | — |
Ironwood Pharmaceuticals quarterly return on equity
Q2.11
Q3.11
Q4.11
Q3.12
Q3.13
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2023 | 2023-06-30 | −588.23% | −595.29 pp |
| Q1 2023 | 2023-03-31 | 6.73% | −0.18 pp |
| Q4 2022 | 2022-12-31 | 7.86% | +0.88 pp |
| Q3 2022 | 2022-09-30 | 8.95% | −1.28 pp |
| Q2 2022 | 2022-06-30 | 7.06% | −118.77 pp |
| Q1 2022 | 2022-03-31 | 6.91% | −39.30 pp |
| Q4 2021 | 2021-12-31 | 6.98% | −119.08 pp |
| Q3 2021 | 2021-09-30 | 10.23% | — |
| Q2 2021 | 2021-06-30 | 125.83% | — |
| Q1 2021 | 2021-03-31 | 46.20% | — |
| Q4 2020 | 2020-12-31 | 126.06% | — |
| Q2 2017 | 2017-06-30 | −256.32% | −231.13 pp |
| Q1 2017 | 2017-03-31 | −108.98% | −94.68 pp |
| Q4 2016 | 2016-12-31 | −21.41% | — |
| Q3 2016 | 2016-09-30 | −47.15% | — |
| Q2 2016 | 2016-06-30 | −25.19% | — |
| Q1 2016 | 2016-03-31 | −14.29% | — |
| Q3 2013 | 2013-09-30 | −55.25% | −85.89 pp |
| Q3 2012 | 2012-09-30 | 30.64% | +47.62 pp |
| Q4 2011 | 2011-12-31 | −6.26% | — |
| Q3 2011 | 2011-09-30 | −16.98% | — |
| Q2 2011 | 2011-06-30 | −13.01% | — |
Ironwood Pharmaceuticals return on equity trends
Between the periods ended 2011-12-31 and 2023-12-31, Ironwood Pharmaceuticals's return on equity decreased from −48.14% to −654.88%, a change of −606.74 percentage points. The latest reported quarter, Q2 2023, shows −588.23%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ironwood Pharmaceuticals source filings ↗